Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Liuhe Dan ointment for abdominal pain in acute pancreatitis
ChiCTR2400085136Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2024
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liuhe dan in acute pancreatitis (AP) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Time to disappearance of abdominal pain. Planned start May 2024; status: not yet recruiting.
02
Drugs
liuhe dan
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR2400085136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085136.